No matches

4 search results for: eosinophils

<b>Eosinophils</b> as a Biomarker for Type 2 Asthma
Pulmonology
Eosinophils as a Biomarker for Type 2 Asthma
expert video

Dr. Elliot Israel presents the utility of eosinophils as a biomarker of type 2 inflammation and their role in the disease burden of asthma.

View more
More Than <b>Eosinophils</b>: A Closer Look at the Pathophysiology of EoE
Gastroenterology
More Than Eosinophils: A Closer Look at the Pathophysiology of EoE
expert video

Join Prof. Kathryn Peterson for an expert review on how different immune cells and inflammatory mediators contribute to the pathogenesis of EoE.

View more
National Eosinophil Awareness Week 2024 | May 19-25
Awareness Day
19
May
2024
Awareness Day
National Eosinophil Awareness Week 2024 | May 19-25

In recognition of National Eosinophil Awareness Week, ADVENT is providing medical education resources to increase awareness of eosinophilic esophagitis (EoE).

View more
Type 2 Inflammation Underpins Pediatric Severe Asthma
Pulmonology
Type 2 Inflammation Underpins Pediatric Severe Asthma
Infographic

Learn about the role type 2 inflammation plays in the burden and pathophysiology of severe asthma in pediatric patients.

View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: FranceChange country/region